Therapeutics and COVID-19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Morten H. Møller; Michelle S. Chew; Klaus T. Olkkola; Marius Rehn; Arvi Yli-Hankala; Martin I. Sigurðsson

doi:10.1111/aas.14046

Therapeutics and COVID-19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Morten H. Møller, Michelle S. Chew, Klaus T. Olkkola, Marius Rehn, Arvi Yli-Hankala, Martin I. Sigurðsson

Research output: Contribution to journal › Article › Scientific

1 Downloads (Pure)

Abstract

The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

Original language	English
Pages (from-to)	636-637
Journal	ACTA ANAESTHESIOLOGICA SCANDINAVICA
Volume	66
Issue number	5
DOIs	https://doi.org/10.1111/aas.14046
Publication status	Published - Apr 2022
Publication type	B1 Journal article

Keywords

AGREE II
clinical practice guideline
COVID-19
therapeutics
WHO

ASJC Scopus subject areas

Anesthesiology and Pain Medicine

Access to Document

10.1111/aas.14046Licence: CC BY

Acta Anaesthesiol Scand - 2022 - M ller - Therapeutics and COVID%u201019 A living WHO guideline Endorsement by the ScandinavianFinal published version, 365 KBLicence: CC BY

https://urn.fi/URN:NBN:fi:tuni-202206275830Licence: CC BY

Cite this

@article{be1e07b8ecaf4ecd9f3ef0a8e473ff0d,

title = "Therapeutics and COVID-19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine",

abstract = "The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.",

keywords = "AGREE II, clinical practice guideline, COVID-19, therapeutics, WHO",

author = "M{\o}ller, {Morten H.} and Chew, {Michelle S.} and Olkkola, {Klaus T.} and Marius Rehn and Arvi Yli-Hankala and Sigur{\dh}sson, {Martin I.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.",

year = "2022",

month = apr,

doi = "10.1111/aas.14046",

language = "English",

volume = "66",

pages = "636--637",

journal = "ACTA ANAESTHESIOLOGICA SCANDINAVICA",

issn = "0001-5172",

publisher = "Wiley",

number = "5",

}

TY - JOUR

T1 - Therapeutics and COVID-19—A living WHO guideline

T2 - Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

AU - Møller, Morten H.

AU - Chew, Michelle S.

AU - Olkkola, Klaus T.

AU - Rehn, Marius

AU - Yli-Hankala, Arvi

AU - Sigurðsson, Martin I.

PY - 2022/4

Y1 - 2022/4

N2 - The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

AB - The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

KW - AGREE II

KW - clinical practice guideline

KW - COVID-19

KW - therapeutics

KW - WHO

U2 - 10.1111/aas.14046

DO - 10.1111/aas.14046

M3 - Article

C2 - 35170027

AN - SCOPUS:85125900433

SN - 0001-5172

VL - 66

SP - 636

EP - 637

JO - ACTA ANAESTHESIOLOGICA SCANDINAVICA

JF - ACTA ANAESTHESIOLOGICA SCANDINAVICA

IS - 5

ER -

Therapeutics and COVID-19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this